Financial Performance: Agios Pharmaceuticals' revenue, earnings, and profitability heavily influence its stock price. Strong financial results often lead to increased investor confidence.

Clinical Trial Results: Positive clinical trial outcomes for Agios' drug candidates typically boost the stock. Conversely, negative results can cause a price decline.

Regulatory Approvals: FDA approvals for Agios' therapies are major catalysts for price increases. Delays or rejections can negatively impact the stock.

Competition: The competitive landscape in Agios' therapeutic areas affects its market share and pricing power, impacting stock performance.

Market Conditions: Overall market sentiment, economic conditions, and industry trends influence investor appetite for biotech stocks like Agios.

Partnerships & Acquisitions: Strategic collaborations or potential acquisitions can positively affect AGIO's stock price.

Pipeline Development: Progress and expansion of Agios' drug development pipeline can generate investor excitement and drive up the stock price.